Background: Since early antimicrobial therapy is mandatory in septic patients, immediate diagnosis and distinction from non-infectious SIRS is essential but hampered by the similarity of symptoms between both entities. We aimed to develop a diagnostic model for differentiation of sepsis and non-infectious SIRS in critically ill children based on routinely available parameters (baseline characteristics, clinical/laboratory parameters, technical/medical support).
Methods: This is a secondary analysis of a randomized controlled trial conducted at a German tertiary-care pediatric intensive care unit (PICU). Two hundred thirty-eight cases of non-infectious SIRS and 58 cases of sepsis (as defined by IPSCC criteria) were included. We applied a Random Forest approach to identify the best set of predictors out of 44 variables measured at the day of onset of the disease. The developed diagnostic model was validated in a temporal split-sample approach.
Results: A model including four clinical (length of PICU stay until onset of non-infectious SIRS/sepsis, central line, core temperature, number of non-infectious SIRS/sepsis episodes prior to diagnosis) and four laboratory parameters (interleukin-6, platelet count, procalcitonin, CRP) was identified in the training dataset. Validation in the test dataset revealed an AUC of 0.78 (95% CI: 0.70-0.87). Our model was superior to previously proposed biomarkers such as CRP, interleukin-6, procalcitonin or a combination of CRP and procalcitonin (maximum AUC = 0.63; 95% CI: 0.52-0.74). When aiming at a complete identification of sepsis cases (100%; 95% CI: 87-100%), 28% (95% CI: 20-38%) of non-infectious SIRS cases were assorted correctly.
Conclusions: Our approach allows early recognition of sepsis with an accuracy superior to previously described biomarkers, and could potentially reduce antibiotic use by 30% in non-infectious SIRS cases. External validation studies are necessary to confirm the generalizability of our approach across populations and treatment practices.
Trial Registration: ClinicalTrials.gov number: NCT00209768; registration date: September 21, 2005.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853156 | PMC |
| http://dx.doi.org/10.1186/s12887-018-1082-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population.
J Clin Med
October 2024
Immunexpress Inc., Seattle, WA 98109, USA.
SeptiCyte RAPID is a transcriptional host response assay that discriminates between sepsis and non-infectious systemic inflammation (SIRS) with a one-hour turnaround time. The overall performance of this test in a cohort of 419 patients has recently been described [Balk et al., J Clin Med 2024, 13, 1194].
View Article and Find Full Text PDFNeutrophil-to-Lymphocyte Ratio Predicts Sepsis in Adult Patients Meeting Two or More Systemic Inflammatory Response Syndrome Criteria.
West J Emerg Med
September 2024
St. Luke's University Health Network, Bethlehem, Pennsylvania.
Introduction: Determining which patients who meet systemic inflammatory response syndrome (SIRS) criteria have bacterial sepsis is a difficult challenge for emergency physicians. We sought to determine whether the neutrophil-to-lymphocyte ratio (NLR) could be used to exclude bacterial sepsis in adult patients who meet ≥2 SIRS criteria and are being evaluated for sepsis.
Methods: Consenting adult patients meeting ≥2 SIRS criteria and undergoing evaluation for sepsis were enrolled.
The new pattern for dual NOTCH pathway involving nuclear transcription and mitochondrial regulation supports therapeutic mechanism of 4-butyl benzophenone derivatives against SIRS.
Free Radic Biol Med
October 2024
School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, PR China; School of Public Health, Shaanxi University of Chinese Medicine, Xi'an 712046, PR China. Electronic address:
Article Synopsis
- SIRS is an inflammatory response triggered by various factors, analyzed in mice to identify key proteins and potential treatments.
- NOTCH1 was pinpointed as a crucial target, with new chemical derivatives showing promising anti-inflammatory effects by interacting with NOTCH1.
- One derivative, D6, functions through two pathways: inhibiting NOTCH1's transcriptional activity and enhancing mitochondrial health, while the activator Jagged1 and inhibitor DAPT modulate these actions.
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation.
J Clin Med
February 2024
Immunexpress Inc., Seattle, DC 98109, USA.
Article Synopsis
- SeptiCyte RAPID is a molecular test designed to differentiate between sepsis and non-infectious systemic inflammation, utilizing a blood RNA sample to deliver results in about one hour.
- A study tested both retrospective and prospective patient samples in ICU settings, with physicians evaluating cases without knowledge of the test outcomes.
- The test showed strong performance, especially under the Sepsis-2 criteria, with high AUC values and predictive capabilities, indicating it is a crucial tool for diagnosing sepsis, though some discrepancies were noted when compared to the Sepsis-3 criteria.
Accuracy of procalcitonin for diagnosing sepsis in adult patients admitted to the emergency department: a systematic review and meta-analysis.
Syst Rev
January 2024
Hamad Medical Corporation Doha, Ar-Rayyan, Qatar.
Background: Differentiating sepsis from non-infectious systemic inflammatory response syndrome (SIRS) is challenging. Biomarkers like procalcitonin (PCT) aid early risk assessment and guide antibiotic use. This study aims to ascertain PCT's accuracy as a sepsis biomarker among adult emergency department admissions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!